Targeting MARCO in combination with anti-CTLA-4 leads to enhanced melanoma regression and immune cell infiltration via macrophage reprogramming is a research paper published in Journal for ImmunoTherapy of Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Grant: N/A
NIH
Grant: 1R01 CA148995
NIH
Grant: 1R01 CA184845
NIH
Grant: P30 CA076292
NIH
Grant: P50 CA168536
National Institutes of Health
Grant: 3P30CA076292-24S2
Moffitt Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA148995-04
Designing Lymph Nodes for Cancer Immunotherapy
National Institutes of Health
Grant: 1P50CA168536-01A1
Biostatistics
National Institutes of Health
Grant: 1R01CA184845-01
Biomarkers and Resistance Mechanisms in Melanoma T-cell Therapy
FWCI
3.57
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals